Neurogene, Inc. (NGNE)
28.31
-2.94
(-9.41%)
USD |
NASDAQ |
Sep 25, 16:00
28.32
+0.01
(+0.04%)
After-Hours: 19:59
Neurogene Market Cap : 448.16M for Sept. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 25, 2026 | 448.16M |
| September 24, 2026 | 494.70M |
| September 23, 2026 | 489.64M |
| September 22, 2026 | 531.90M |
| September 21, 2026 | 515.60M |
| September 18, 2026 | 508.00M |
| September 17, 2026 | 513.07M |
| September 16, 2026 | 548.84M |
| September 15, 2026 | 533.33M |
| September 14, 2026 | 557.39M |
| September 11, 2026 | 561.67M |
| September 10, 2026 | 571.80M |
| September 09, 2026 | 599.66M |
| September 08, 2026 | 603.62M |
| September 04, 2026 | 611.06M |
| September 03, 2026 | 595.39M |
| September 02, 2026 | 607.26M |
| September 01, 2026 | 599.50M |
| August 31, 2026 | 573.70M |
| August 28, 2026 | 579.08M |
| August 27, 2026 | 599.34M |
| August 26, 2026 | 608.05M |
| August 25, 2026 | 646.52M |
| August 24, 2026 | 627.52M |
| August 21, 2026 | 611.53M |
| Date | Value |
|---|---|
| August 20, 2026 | 601.40M |
| August 19, 2026 | 624.20M |
| August 18, 2026 | 564.67M |
| August 17, 2026 | 580.66M |
| August 14, 2026 | 572.11M |
| August 13, 2026 | 564.04M |
| August 12, 2026 | 585.41M |
| August 11, 2026 | 566.73M |
| August 10, 2026 | 578.60M |
| August 07, 2026 | 564.99M |
| August 06, 2026 | 563.57M |
| August 05, 2026 | 561.86M |
| August 04, 2026 | 537.34M |
| August 03, 2026 | 513.29M |
| July 31, 2026 | 513.60M |
| July 30, 2026 | 524.69M |
| July 29, 2026 | 525.63M |
| July 28, 2026 | 518.76M |
| July 27, 2026 | 540.62M |
| July 24, 2026 | 544.99M |
| July 23, 2026 | 555.45M |
| July 22, 2026 | 563.89M |
| July 21, 2026 | 572.79M |
| July 20, 2026 | 583.09M |
| July 17, 2026 | 582.63M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.560B |
| Alnylam Pharmaceuticals, Inc. | 34.23B |
| Anika Therapeutics, Inc. | 272.61M |
| Savara, Inc. | 1.027B |
| Vericel Corp. | 2.032B |
Market Cap Related Metrics
| PEG Ratio | -0.2731 |
| Price to Book Value | 2.064 |
| Price | 28.31 |
| Earnings Yield | -19.44% |
| PEGY Ratio | -0.2731 |